International Journal of Molecular Sciences · 2018 · 34 citations · 38 references
MedicineMedicinal ChemistryPharmacologyApoptosisCancer PharmacologyMolecular OncologyApoptosis In CancerApoptosis PharmacologyApoptosis RegulationCell DeathDeath ReceptorsOncology PharmacologyAnti-apoptotic AgentsAnticancer ActivityCancer Cell ApoptosisDrug-induced ApoptosisPro-apoptotic AgentsScaffold Protein InteractionsScaffold Protein SignalingWestern Blotting
)(1,3) diazepino(1,2-a)-(1,8)naphthyridin-6-yl)(phenyl) methanone (named 3u), showed good anticancer activity in the human malignant melanoma cell line A375 via Thiazolyl Blue Tetrazolium Bromide (MTT) assay. After Western blotting confirmed, we found that 3u induces necroptosis at low concentrations and apoptosis at high concentrations via the upregulation of death receptors and scaffold protein in A375 cells. Furthermore, by combining 3u with the caspase inhibitor zVAD-fmk or Receptor Interacting Serine/Threonine Kinase 1 (RIP1) kinase inhibitor Necrostatin-1 (Nec-1), we found that the activity of caspase-8 was the crucial factor that determined whether either apoptosis or necroptosis occurred. The results indicate that 3u should be considered as a potential chemical substance for melanoma treatment.
38
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
Mutations of the BRAF gene in human cancer
Helen Davies, Graham R. Bignell, Charles Cox et al. · Nature · 2002 · 10.7K citations
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
Martin D. Bootman, Ludwig Missiaen, Jan B. Parys et al. · Biochemical Journal · 1995 · 5.1K citations
Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β
Toshiyuki Nakagawa, Hong Zhu, Nobuhiro Morishima et al. · Nature · 2000 · 3.3K citations